PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2014 | 63 | 3 | 325-330
Article title

Żelazo w neurodegeneracji

Content
Title variants
EN
Iron in neurodegenerative diseases
Languages of publication
PL EN
Abstracts
PL
W pracy omówiono możliwą rolę żelaza w powstawaniu chorób neurodegeneracyjnych, takich jak choroba Parkinsona, choroba Alzheimera i postępujące porażenie nadjądrowe (PSP). Otrzymane wyniki sugerują różne mechanizmy prowadzące do śmierci komórek nerwowych w tych chorobach.
EN
In this review we discuss the possible role of iron in induction of neurodegenerative disease like Parkinson's disease, Alzheimer disease and progressive supranuclear palsy (PSP). Our results suggest different mechanisms leading to nervous cells death in these diseases.
Keywords
Journal
Year
Volume
63
Issue
3
Pages
325-330
Physical description
Dates
published
2014
Contributors
  • Wydział Fizyki, Politechnika Warszawska, Koszykowa 75, 00-662 Warszawa, Polska
  • Klinika Neurologii, Warszawski Uniwersytet Medyczny, Kondratowicza 8, 03-242 Warszawa, Polska
References
  • Bauminger E. R., Barcikowska M., Friedman A., Galazka-Friedman J., Hechel D., Nowik I., 1994. Does iron play a role in Parkinson's disease? Hyperfin. Interact. 91, 853-856.
  • Earle K. M., 1968. Studies on Parkinson's disease including X-ray fluorescent spectroscopy of formalin fixed brain tissue. J. Neuropathol. Exp. Neurol. 27, 1-13.
  • Friedman A., Arosio P., Finazzi D., Koziorowski D., Galazka-Friedman J., 2011. Ferritin as an important player in neurodegeneration. Park. Rel. Disord. 17, 423-430.
  • Galazka-Friedman J., Friedman A., 1997. Controversies about iron in parkinsonian and control substantia nigra. Acta Neurobiol. Exp. 57, 210-225.
  • Galazka-Friedman J., Bauminger E. R., Friedman A., Barcikowska M., Hechel D., Nowik I., 1996. Iron in parkinsonian and control substantia nigra - a M(o)ssbauer spectroscopy study. Mov. Disord. 11, 8-16.
  • Galazka-Friedman J., Friedman A., Bauminger E. R., 2009a. Iron in the brain. Hyperfine Interact. 189, 31-37.
  • Galazka-Friedman J., Bauminger E. R., Szlachta K., Schweitzer K., Wszolek Z., Dickson D., Friedman A., 2009b. Mössbauer studies of pathological brain tissues affected by PSP disease. Acta Phys. Pol. 115, 431-433.
  • Galazka-Friedman J., Bauminger E. R., Szlachta K., Koziorowski D., Tomasiuk R., Jaklewicz A., Wszolek Z.K., Dickson D., Kaplinska K., Friedman A., 2011. Iron in Alzheimer and control hippocampi - Mössbauer, atomic absorption and ELISA studies. Acta Phys. Pol. 119, 81-83.
  • Galazka-Friedman J., Bauminger E. R., Friedman A., 2013 Iron in neurodegeneration. [W:] Mössbauer spectroscopy- Applications in chemistry, biology and nanotechnology. Sharma V. K., Klingelhöfer G., Nishida T. (red.). Wiley, Hoboken New Jersey, 324-332.
  • Griffiths P. D., Crossman A. R., 1993. Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease. Dementia 4, 61-65.
  • Jellinger K., Kienzl E., Rumpelmair G., Riederer P., Stachelberger H., Ben-Shachar D., Youdim M. B. H., 1992. Iron-melanin complex in substantia nigra of parkinsonian brains: an Xray microanalysis. J. Neurochem. 59, 1168-1171.
  • Koziorowski D., Friedman A., Arosio P., Santambrogio P., Dziewulska D., 2007. ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and Incidental Lewy Body compared to control. Park. Rel. Disord. 13, 214-218.
  • Loeffler D. A., Connor J. R., Juneau P. L., Snyder B. S., Kanaley L., DeMaggio A. J., Nguyen H., Brickman C. M., LeWitt P. A., 1995. Transferrin and iron in normal. Alzheimer's disease. and Parkinson's disease brain regions. J. Neurochem. 65, 710-716.
  • Mann V. M., Cooper J. M., Daniel S. E., Srai K., Jenner O., Marsden C. D., Schapira A. H. V., 1994. Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Ann. Neurol. 36, 876-881.
  • Sofic E., Riederer P., Heinsen H., Beckmann H., Reynolds G. P., Hebenstreit G., Youdim M. B. H., 1988. Increased iron (111) and total iron content in post mortem substantia nigra of parkinsonian brain. J. Neural. Trans. 74, 199-205.
  • Wypijewska A., Galazka-Friedman J., Bauminger E. R., Wszolek Z. K., Schweitzer K. J., Dickson D. W., Jaklewicz A., Elbaum D., Friedman A., 2010. Iron and reactive oxygen species activity in parkinsonian substantia nigra. Park. Rel. Disord. 16, 329-333.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.bwnjournal-article-ksv63p325kz
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.